The Effect of Rebamipide for the Patients with Reflux Esophagitis

The Effect of Rebamipide for the Patients with Reflux Esophagitis rebamipide Rebamipide is a gastroprotective agent with promising results against gastric damage induced by non-steroidal anti-inflammatory drugs rebamipide Rebamipide can prevent gastric ulcers when used with NSAIDs and can decrease the gastrointestinal symptoms associated with NSAID administration When the

rebamipide Compared with placebo, rebamipide significantly promoted gastric ulcer healing following 1 week of eradication therapy in a randomized, double-blind,

rebamipide General improvement rate was remarkable % and effectiveness rate of Rebamipide was % after 8 weeks of treatment No significant clinical side effects Customer Review · Description Rebamipide is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially